Loomis, Sayles & Company’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Sell
162,986
-5,843
-3% -$456K 0.02% 315
2025
Q4
$13.3M Sell
168,829
-3,314
-2% -$287K 0.02% 307
2025
Q3
$15.8M Sell
172,143
-34,239
-17% -$2.79M 0.02% 277
2025
Q2
$13.5M Buy
206,382
+12,494
+6% +$813K 0.02% 311
2025
Q1
$13M Sell
193,888
-297
-0.2% -$17.7K 0.02% 307
2024
Q4
$10.7M Buy
194,185
+19,568
+11% +$1.12M 0.01% 358
2024
Q3
$10.4M Sell
174,617
-6,831
-4% -$417K 0.01% 353
2024
Q2
$11.6M Buy
181,448
+1,105
+0.6% +$71.7K 0.02% 338
2024
Q1
$12.5M Sell
180,343
-86
-0% -$5.19K 0.02% 324
2023
Q4
$9.95M Buy
180,429
+15,200
+9% +$837K 0.02% 336
2023
Q3
$9.59M Sell
165,229
-3,426
-2% -$198K 0.02% 340
2023
Q2
$9.08M Buy
168,655
+64,643
+62% +$2.87M 0.01% 355
2023
Q1
$4.13M Buy
+104,012
New +$4.39M 0.01% 408
2018
Q4
Sell
-108
Closed -$6K 843
2018
Q3
$6K Hold
108
﹤0.01% 870
2018
Q2
$7K Hold
108
﹤0.01% 848
2018
Q1
$6K Hold
108
﹤0.01% 853
2017
Q4
$7K Sell
108
-300
-74% -$18.7K ﹤0.01% 813
2017
Q3
$21K Buy
408
+31
+8% +$1.48K ﹤0.01% 755
2017
Q2
$18K Buy
377
+256
+212% +$12.3K ﹤0.01% 767
2017
Q1
$6K Buy
121
+18
+17% +$1.01K ﹤0.01% 850
2016
Q4
$6K Hold
103
﹤0.01% 883
2016
Q3
$7K Hold
103
﹤0.01% 818
2016
Q2
$6K Sell
103
-24
-19% -$1.17K ﹤0.01% 812
2016
Q1
$4K Sell
127
-119
-48% -$4.04K ﹤0.01% 948
2015
Q4
$11K Buy
+246
New +$10.6K ﹤0.01% 846

Other funds holding ANIP